accountnew drug application to the U.S. Food and Drug Administration (FDA) for its experimental acute migraine drug.
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
ALLERGAN INC.
Allergan, Inc. is a global, multi-specialty healthcare company that operates in two business segments: specialty pharmaceuticals and medical devices. Their products include ophthalmic pharmaceuticals, dermatology products, and neurological products. Allergan, Inc.’s most notable product is Botox, which is used for therapeutic and aesthetic indications. The company was founded in 1948 and is headquartered in Irvine, California.
Allergan Inc. is part of Business Exchange, suggested by
Ulli Muenker.
This topic contains
244 news
and
82 blog
items.
Read updated news, blogs, and resources about Allergan Inc.. Find user-submitted articles and reactions on Allergan Inc. from
like-minded professionals.
News
Please add new articles to this topic
reported positive results from its Phase 3 trial of LEVADEX and has entered into a collaboration agreement with...
the Chief Executive Officer of Peregrine Pharmaceuticals and held senior management positions with Cypress Biosciences,...
current and future competition in the seven key countries retinal vein occlusion market. Key market players covered are...
Allergan Inc (AGN.N), whose biggest drug is the Botox anti-wrinkle injections, won a round in its fight to defend its...
people as young as 14. But that worries some experts. With sales of its Lap-Band weight-loss device declining, Allergan...
Stock Screener and watch exclusively on TheStreet.com. More on AGN Allergan, BMC: New Targets, Estimates Market...
daily report on global news about patents, trademarks, copyright and other intellectual property topics.
and Rhinoplasty), and Non-Surgical Procedures. The report profiles 76 companies including many key and niche players...
LIPOSUCTION TABLE 106 PATENTS FOR WATER-ASSISTED LIPOSUCTION TABLE 107 OTHER ASSISTED-LIPOSUCTION PATENTS CHAPTER...
certainly shouldn't be subjected to this procedure." Botox is a key revenue driver for its maker Allergan Inc.
Biesen puts it: "The generic drug cabinet, so to speak, works." SPECIALISTS SIT PRETTY Instead, companies...
expert Tim van Biesen puts it: "The generic drug cabinet, so to speak, works." Instead, companies like...
to smoothing out wrinkled brows, the market is rebounding, according to David Pyott, chief executive of Botox maker...
injectable products including Propofol Injectable Emulsion. Additionally, Dr. Mirejovsky has had similar roles at ISIS...
NEW DELHI: US-based Allergan Inc today announced the launch of its anaesthetic dermal filler 'Juvederm XC', used to...
blocking chemical signals from nerves that stimulate sweat production, says Frederick Beddingfield, vice president of...
blocking chemical signals from nerves that stimulate sweat production, says Frederick Beddingfield, vice president of...
of 2010, reflecting a reduction in the applicable royalty rate associated with an amendment to the agreement with...
Phase II for chronic pain and a product candidate in Phase I for glaucoma, both in collaboration with Allergan, Inc.
to participate in a Facial Aesthetics Advisory Panel in New York City on Thursday, June 9, hosted by Allergan, Inc.
and other organisations active in the Metabolic Syndrome research field. Sample companies in database include: Actelion...
The face is the one outfit you get to wear every day." -- David Pyott, CEO of Allergan Inc (AGN.N "Sometimes...
Allergan Inc's (AGN.N) CEO said the company could deliver double-digit profit growth over the next five years, fueled...
2 FINANCIALS 8.2.3 PRODUCTS & SERVICES 8.2.4 STRATEGY 8.2.5 DEVELOPMENTS 8.3 ALLERGAN INC. 8.3.1 OVERVIEW 8.3.
Top Sources: Allergan Inc.
- grinza.com
- Reuters
- MarketWatch
- TheDeal.com
- ocbj.com
- Wall Street Journal Online
- BusinessWeek
- Los Angeles Times
- Morningstar.com
- CNN Money
